Acute venous thromboembolism (VTE), including deep venous thrombosis (DVT) and pulmonary embolism (PE), are the most common preventable causes of hospital death and a source of substantial long-term morbidity. The impact on health is so great that the Surgeon General…
Venous thromboembolism (VTE), which includes both deep venous thrombosis (DVT) and pulmonary embolism (PE), is very common. Although the etiology of acute venous thrombosis (VT) is defined by Virchow triad of hypercoagulability, stasis, and endothelial injury, it is clearly a…
There are many pharmacologic options in current use to treat and prevent venous thromboembolism (VTE). These medications include unfractionated heparin (UFH), low-molecular-weight heparins (LMWHs), factor Xa inhibitors (anti-Xa drugs), direct thrombin inhibitors (anti-IIa drugs), and vitamin K antagonists. UFH and…